Ceftazidime For Inj. 125 Mg/250mg /500mg/1000mg

What is Ceftazidime for Injection?

Ceftazidime for Injection is a third-generation cephalosporin antibiotic formulation used by healthcare professionals to treat selected bacterial infections caused by susceptible organisms. It works by interfering with bacterial cell-wall synthesis. The listed strengths are 125mg, 250mg, 500mg and 1000mg, with product use and administration guided by approved prescribing information and clinical assessment.

Uses / Indications

Ceftazidime may be used for certain bacterial infections caused by susceptible organisms, according to approved product information and applicable treatment guidelines. Potential clinical applications may include:

• Selected lower respiratory tract infections

• Certain urinary tract infections

• Skin and soft-tissue infections

• Bloodstream infections caused by susceptible bacteria

• Bone and joint infections, where indicated

• Other infections specified in the approved prescribing information

The exact approved indications depend on the product labelling, bacterial susceptibility and the patient’s clinical condition.

Benefits

• Provides an injectable formulation of a third-generation cephalosporin antibiotic.

• Acts against susceptible bacteria by inhibiting bacterial cell-wall synthesis.

• Offers multiple listed strengths for healthcare-professional-directed treatment.

• May be considered when injectable antibiotic treatment is clinically appropriate.

Side Effects

Common or Possible Side Effects

• Diarrhoea or loose stools

• Nausea or vomiting

• Skin rash or itching

• Injection-site pain or inflammation

• Changes in liver-function test results

Serious Side Effects

• Severe allergic reactions, including swelling of the face or throat or difficulty breathing

• Severe or persistent diarrhoea

• Severe skin reactions

• Neurological effects such as confusion or seizures, particularly in susceptible patients or when dosing is inappropriate

Seek urgent medical care if a serious allergic reaction or other severe symptom occurs. Refer to the approved product information for the full adverse-effect profile.

How Does It Work?

Ceftazidime belongs to the third-generation cephalosporin class of beta-lactam antibiotics. It binds to bacterial penicillin-binding proteins and interferes with the synthesis of the bacterial cell wall. This weakens the cell wall and can cause susceptible bacteria to die. Its effectiveness depends on the infecting organism and its susceptibility to ceftazidime.

Dosage Guidelines

• The appropriate dose, frequency and treatment duration must be determined by a qualified healthcare professional.

• Dosing depends on the infection, its severity, the patient’s age and clinical condition, and kidney function.

• Preparation, compatibility and administration must follow the approved product information.

• The listed strengths represent product presentations and should not be interpreted as individual dosing instructions.

The exact dose and treatment duration should follow the approved product information and the recommendation of a qualified healthcare professional.

When Not to Use

Ceftazidime may not be appropriate for patients who:

• Have a known serious allergy to ceftazidime or other cephalosporin antibiotics.

• Have a history of severe hypersensitivity to beta-lactam antibiotics, unless a qualified clinician determines that use is appropriate.

• Have another contraindication specified in the approved product information.

The patient’s allergy history and relevant medical conditions should be reviewed before treatment.

Drug / Product Interactions

Potential interactions or precautions may include:

• Medicines that may affect kidney function: additional assessment or monitoring may be needed.

• Other antibiotics: concurrent treatment should be guided by clinical need and product compatibility information.

• Anticoagulants or medicines affecting blood clotting: monitoring may be appropriate in selected patients.

• Laboratory tests: some medicines may affect test interpretation; disclose current treatment when undergoing testing.

The treating healthcare professional should review all prescription medicines, non-prescription products and supplements.

Safety Advice

• Use only under appropriate medical supervision.

• Inform the healthcare professional about previous antibiotic allergies and any kidney conditions.

• Report severe diarrhoea, confusion, seizures or signs of an allergic reaction promptly.

• Use antibiotics only for appropriate bacterial infections; they do not treat viral illnesses.

• Do not share the medicine or use leftover antibiotics without medical advice.

General Instructions

• The product should be prepared and administered by trained healthcare personnel.

• Follow the approved instructions for reconstitution, compatibility and administration.

• Inspect the vial and packaging before use; do not use damaged or questionable products.

• Do not use the product beyond its labelled expiry date.

• Follow the prescribed treatment plan and applicable infection-control procedures.

Special Dietary / Lifestyle Tips

• Follow the treating healthcare professional’s advice about diet and fluid intake.

• Maintain adequate hydration unless medically restricted.

• Seek medical advice if diarrhoea or vomiting becomes persistent or interferes with fluid intake.

• Do not alter the prescribed treatment plan without consulting the treating professional.

Comparison with Other Treatments

Ceftazidime is a third-generation cephalosporin antibiotic. Other cephalosporins and antibiotic classes may be selected according to the infection site, suspected or confirmed bacteria, susceptibility results, allergy history and local treatment guidelines.

Antibiotics are not automatically interchangeable based on class or dosage form. Treatment selection should be made by a qualified healthcare professional.

Precautions & Warnings

• Allergy risk: Review previous reactions to cephalosporins, penicillins and other beta-lactam antibiotics.

• Kidney function: Assessment and dose adjustment may be required in some patients.

• Neurological effects: Patients with kidney impairment or other risk factors may require careful dosing and monitoring.

• Antibiotic-associated diarrhoea: Severe or persistent diarrhoea requires prompt medical assessment.

• Pregnancy and breastfeeding: Use should be assessed by a healthcare professional according to the approved product information.

• Antimicrobial resistance: Use only when clinically indicated and in accordance with appropriate prescribing guidance.

Can I Use It With Other Medicines?

Ceftazidime may be used alongside other medicines when clinically indicated, but the combination should be reviewed by a qualified healthcare professional. Particular attention may be needed for medicines that affect kidney function and other products identified in the approved interaction information. Do not start, stop or change medicines without professional advice.

Storage

Store according to the manufacturer’s approved product labelling. Refer to the product packaging or package insert for the applicable storage conditions.

Frequently Asked Questions

1. What is Ceftazidime for Injection used for?

It is an injectable cephalosporin antibiotic used for selected bacterial infections caused by susceptible organisms, according to approved prescribing information.

2. What strengths are available?

The supplied strengths are 125mg, 250mg, 500mg and 1000mg.

3. Is ceftazidime effective against viral infections?

No. Ceftazidime treats susceptible bacterial infections and does not treat viral illnesses such as influenza or the common cold.

4. Who should administer Ceftazidime for Injection?

Qualified healthcare personnel should prepare and administer the product according to the approved product instructions.

5. What side effects may occur?

Possible effects include diarrhoea, nausea, rash and injection-site reactions. Serious allergic reactions or severe persistent diarrhoea require prompt medical attention.

6. Does kidney function matter when using ceftazidime?

Yes. Kidney function may influence dosing and monitoring, so the treating healthcare professional should be informed of any kidney condition.

7. How should Ceftazidime for Injection be stored?

Follow the storage conditions specified in the approved product labelling and package insert.